4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-052389
CEO sold 51,563 shares at $21.96 ($1,132,323)
- CEO acquired 103,999 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2023-10-05 | Option exercise | +103,999 | 140,694 | D | ||
| DAVIS STEPHEN CEO | 2023-10-06 | Sale | −51,563 | $21.96 | $1,132,323 | 89,131 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2023-10-06 | Option exercise · Restricted Stock Units | −103,999 | 173,332 | D | ||
| Open-market sales · 51,563 sh · avg $21.96 · $1,132,323 | |||||||
Loading xslF345X05/doc4.xml…